MedTrace Logo

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers

NCT05486455 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2022-12-06

No results posted yet for this study

Summary

Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.

Conditions

  • Smoking

Interventions

DIAGNOSTIC_TEST

Low-dose chest CT scan

baseline, 1-year, 3-year and 5-year low-dose CT scan

Sponsors & Collaborators

  • Hospital St. Joseph, Marseille, France

    lead OTHER

Principal Investigators

  • Arnaud Boyer, MD · Hopital Saint Joseph Marseille

  • Illies Bouabdallah, MD · Hopital Saint Joseph Marseille

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-04
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05486455 on ClinicalTrials.gov